118 related articles for article (PubMed ID: 27847952)
1. Evaluation of functionalized mesoporous silica SBA-15 as a carrier system for Ph
Bensing C; Mojić M; Gómez-Ruiz S; Carralero S; Dojčinović B; Maksimović-Ivanić D; Mijatović S; Kaluđerović GN
Dalton Trans; 2016 Dec; 45(47):18984-18993. PubMed ID: 27847952
[TBL] [Abstract][Full Text] [Related]
2. The interaction between SBA-15 derivative loaded with Ph
Maksimović-Ivanić D; Bulatović M; Edeler D; Bensing C; Golić I; Korać A; Kaluđerović GN; Mijatović S
J Biol Inorg Chem; 2019 Mar; 24(2):223-234. PubMed ID: 30759278
[TBL] [Abstract][Full Text] [Related]
3. Effect of chain length on the cytotoxic activity of (alkyl-ω-ol)triphenyltin(IV) loaded into SBA-15 nanostructured silica and in vivo study of SBA-15~Cl|Ph
Bensing C; Mojić M; Bulatović M; Edeler D; Pérez-Quintanilla D; Gómez-Ruiz S; Maksimović-Ivanić D; Mijatović S; Kaluđerović GN
Biomater Adv; 2022 Sep; 140():213054. PubMed ID: 35964389
[TBL] [Abstract][Full Text] [Related]
4. Impact of the mesoporous silica SBA-15 functionalization on the mode of action of Ph
Edeler D; Drača D; Petković V; Natalio F; Maksimović-Ivanić D; Mijatović S; Schmidt H; Kaluđerović GN
Mater Sci Eng C Mater Biol Appl; 2019 Jul; 100():315-322. PubMed ID: 30948067
[TBL] [Abstract][Full Text] [Related]
5. Delivery of [Ru(η
Edeler D; Arlt S; Petković V; Ludwig G; Drača D; Maksimović-Ivanić D; Mijatović S; Kaluđerović GN
J Inorg Biochem; 2018 Mar; 180():155-162. PubMed ID: 29288894
[TBL] [Abstract][Full Text] [Related]
6. Antitumor potential of cisplatin loaded into SBA-15 mesoporous silica nanoparticles against B16F1 melanoma cells: in vitro and in vivo studies.
Drača D; Edeler D; Saoud M; Dojčinović B; Dunđerović D; Đmura G; Maksimović-Ivanić D; Mijatović S; Kaluđerović GN
J Inorg Biochem; 2021 Apr; 217():111383. PubMed ID: 33582397
[TBL] [Abstract][Full Text] [Related]
7. Organotin(IV)-loaded mesoporous silica as a biocompatible strategy in cancer treatment.
Bulatović MZ; Maksimović-Ivanić D; Bensing C; Gómez-Ruiz S; Steinborn D; Schmidt H; Mojić M; Korać A; Golić I; Pérez-Quintanilla D; Momčilović M; Mijatović S; Kaluđerović GN
Angew Chem Int Ed Engl; 2014 Jun; 53(23):5982-7. PubMed ID: 24828572
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxicity study of ordered mesoporous silica MCM-41 and SBA-15 microparticles on Caco-2 cells.
Heikkilä T; Santos HA; Kumar N; Murzin DY; Salonen J; Laaksonen T; Peltonen L; Hirvonen J; Lehto VP
Eur J Pharm Biopharm; 2010 Mar; 74(3):483-94. PubMed ID: 20025968
[TBL] [Abstract][Full Text] [Related]
9. Modulation of the mechanism of apoptosis in cancer cell lines by treatment with silica-based nanostructured materials functionalized with different metallodrugs.
Díaz-García D; Cenariu D; Pérez Y; Cruz P; Del Hierro I; Prashar S; Fischer-Fodor E; Gómez-Ruiz S
Dalton Trans; 2018 Sep; 47(35):12284-12299. PubMed ID: 30112529
[TBL] [Abstract][Full Text] [Related]
10. Carboxylic modified spherical mesoporous silicas аs drug delivery carriers.
Popova MD; Szegedi Á; Kolev IN; Mihály J; Tzankov BS; Momekov GT; Lambov NG; Yoncheva KP
Int J Pharm; 2012 Oct; 436(1-2):778-85. PubMed ID: 22884833
[TBL] [Abstract][Full Text] [Related]
11. Mesoporous silica microparticles enhance the cytotoxicity of anticancer platinum drugs.
Tao Z; Toms B; Goodisman J; Asefa T
ACS Nano; 2010 Feb; 4(2):789-94. PubMed ID: 20131868
[TBL] [Abstract][Full Text] [Related]
12. Preparation of efficient quercetin delivery system on Zn-modified mesoporous SBA-15 silica carrier.
Trendafilova I; Szegedi A; Mihály J; Momekov G; Lihareva N; Popova M
Mater Sci Eng C Mater Biol Appl; 2017 Apr; 73():285-292. PubMed ID: 28183610
[TBL] [Abstract][Full Text] [Related]
13. Active targeting co-delivery system based on hollow mesoporous silica nanoparticles for antitumor therapy in ovarian cancer stem-like cells.
Guo X; Guo N; Zhao J; Cai Y
Oncol Rep; 2017 Sep; 38(3):1442-1450. PubMed ID: 28731164
[TBL] [Abstract][Full Text] [Related]
14. Immobilization of Zidovudine Derivatives on the SBA-15 Mesoporous Silica and Evaluation of Their Cytotoxic Activity.
Lewandowski D; Lewandowska M; Ruszkowski P; Pińska A; Schroeder G
PLoS One; 2015; 10(5):e0126251. PubMed ID: 25942021
[TBL] [Abstract][Full Text] [Related]
15. Dual-pore mesoporous carbon@silica composite core-shell nanospheres for multidrug delivery.
Fang Y; Zheng G; Yang J; Tang H; Zhang Y; Kong B; Lv Y; Xu C; Asiri AM; Zi J; Zhang F; Zhao D
Angew Chem Int Ed Engl; 2014 May; 53(21):5366-70. PubMed ID: 24764082
[TBL] [Abstract][Full Text] [Related]
16. MT-4 suppresses resistant ovarian cancer growth through targeting tubulin and HSP27.
Pai HC; Kumar S; Shen CC; Liou JP; Pan SL; Teng CM
PLoS One; 2015; 10(4):e0123819. PubMed ID: 25874627
[TBL] [Abstract][Full Text] [Related]
17. Curcumin-loaded silica-based mesoporous materials: Synthesis, characterization and cytotoxic properties against cancer cells.
Bollu VS; Barui AK; Mondal SK; Prashar S; Fajardo M; Briones D; Rodríguez-Diéguez A; Patra CR; Gómez-Ruiz S
Mater Sci Eng C Mater Biol Appl; 2016 Jun; 63():393-410. PubMed ID: 27040234
[TBL] [Abstract][Full Text] [Related]
18. Functional fluorescent nonporous silica nanoparticles as carriers for Pt(IV) anticancer prodrugs.
Ravera M; Perin E; Gabano E; Zanellato I; Panzarasa G; Sparnacci K; Laus M; Osella D
J Inorg Biochem; 2015 Oct; 151():132-42. PubMed ID: 26277416
[TBL] [Abstract][Full Text] [Related]
19. Intracellular pH-Triggered, Targeted Drug Delivery to Cancer Cells by Multifunctional Envelope-Type Mesoporous Silica Nanocontainers.
Yang K; Luo H; Zeng M; Jiang Y; Li J; Fu X
ACS Appl Mater Interfaces; 2015 Aug; 7(31):17399-407. PubMed ID: 26196506
[TBL] [Abstract][Full Text] [Related]
20. Cisplatin-cyclooxygenase inhibitor conjugates, free and immobilised in mesoporous silica SBA-15, prove highly potent against triple-negative MDA-MB-468 breast cancer cell line.
Predarska I; Saoud M; Morgan I; Eichhorn T; Kaluđerović GN; Hey-Hawkins E
Dalton Trans; 2022 Jan; 51(3):857-869. PubMed ID: 34877948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
